Bologna, Italy

Stefano Luca Giaffreda

This inventor holds 9 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Novartis Ag, Abiogen Pharma S.p.a., Tonix Pharma Holdings Limited. Active years: 2015-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefano Luca Giaffreda. Retrieved from https://idiyas.com/inventor/stefano-luca-giaffreda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Bologna, IT (2015 - 2022)
  • Imola, IT (2022)

Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stefano Luca Giaffreda

Introduction

Stefano Luca Giaffreda is a notable inventor based in Bologna, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new processes for drug preparation. With a total of 9 patents to his name, Giaffreda's work exemplifies innovation and dedication to improving healthcare solutions.

Latest Patents

One of his latest patents is a process for the preparation of the polymorph F of sodium neridronate. This invention outlines a new method for creating the crystalline polymorph of sodium neridronate in hemihydrate form F. The process involves several steps, including the reaction of 6-aminohexanoic acid with phosphorous acid and methanesulfonic acid, followed by a series of heating, cooling, and neutralization steps. This method is particularly noted for being simple, scalable, and environmentally sustainable. Another significant patent involves the crystalline polymorphs of 1,6-dibromo-1,6-dideoxy-dulcitol, which is recognized as an antitumor agent. This patent describes new polymorphic forms and methods for using them in cancer treatment.

Career Highlights

Throughout his career, Giaffreda has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Tonix Pharma Holdings Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in drug formulation.

Collaborations

Stefano has collaborated with esteemed colleagues such as Serena Fabbroni and Michel Chiarucci. These partnerships have fostered a collaborative environment that enhances innovation and drives successful outcomes in their projects.

Conclusion

Stefano Luca Giaffreda's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing healthcare solutions. His work continues to impact the industry positively, paving the way for future developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…